Multiple Myeloma
Showing NaN - NaN of 57
Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)
Not yet recruiting
- Multiple Myeloma
- idecabtagene vicleucel
- +3 more
-
Gilbert, Arizona
- +107 more
Sep 26, 2023
Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Orange, California
- +270 more
Apr 11, 2023
Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)
Recruiting
- Multiple Myeloma
-
Benowa, Queensland, Australia
- +132 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- JNJ-68284528
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Daratumumab, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +2 more
-
Little Rock, Arkansas
- +145 more
Jan 17, 2023
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)
Active, not recruiting
- Multiple Myeloma
- Dara SC
- Dara IV
-
Boston, Massachusetts
- +145 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +150 more
Dec 9, 2022
Multiple Myeloma Trial in Belgium, Israel, Spain (Daratumumab, JNJ-63723283)
Completed
- Multiple Myeloma
-
Antwerpen, Belgium
- +12 more
Dec 1, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))
Active, not recruiting
- Multiple Myeloma
- Elranatamab (PF-06863135)
-
Beverly Hills, California
- +75 more
Oct 4, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Multiple Myeloma Trial in Worldwide (Daratumumab Subcutaneous (SC) Administration, Recombinant Human Hyaluronidase [rHuPH20]) SC
Active, not recruiting
- Multiple Myeloma
- Daratumumab Subcutaneous (SC) Administration
- Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Daratumumab
- +4 more
-
Nantes Cedex 1, France
- +19 more
Aug 11, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin frozen liquid
- Belantamab mafodotin lyophilized powder
-
New Haven, Connecticut
- +58 more
Jul 27, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +34 more
Jul 22, 2022
Multiple Myeloma Trial in Worldwide (bb2121)
Active, not recruiting
- Multiple Myeloma
- bb2121
-
San Francisco, California
- +47 more
Jul 18, 2022
Multiple Myeloma Trial in Worldwide (CTX120)
Active, not recruiting
- Multiple Myeloma
- CTX120
-
Chicago, Illinois
- +9 more
Jul 14, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Tucson, Arizona
- +131 more
Jul 1, 2022
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
Multiple Myeloma Trial in Worldwide (isatuximab SAR650984 IV, pomalidomide, dexamethasone)
Active, not recruiting
- Multiple Myeloma
- isatuximab SAR650984 IV
- +4 more
-
Gilbert, Arizona
- +14 more
May 6, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- Pom/dex (Pomalidomide plus low dose Dexamethasone)
-
Tucson, Arizona
- +163 more
Feb 25, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)
Terminated
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- +3 more
-
Boston, Massachusetts
- +15 more
Mar 4, 2022